SB-204741

SB-204741 is a drug that acts as a selective antagonist for the serotonin receptor subtype 5-HT2B. It has been used in scientific research to investigate the function of this receptor, and has been found to have a variety of effects in animal studies, such as reducing appetite and having anti-inflammatory effects.

Pharmacology

SB-204741 is a selective antagonist for the 5-HT2B receptor, meaning it blocks the action of serotonin at this receptor. This can have a variety of effects, as the 5-HT2B receptor is involved in many different physiological processes.

Mechanism of action

SB-204741 works by binding to the 5-HT2B receptor and preventing serotonin from activating it. This can reduce the effects of serotonin in the body, which can have a variety of effects depending on the specific physiological process involved.

Uses in research

SB-204741 has been used in scientific research to investigate the function of the 5-HT2B receptor. It has been found to have a variety of effects in animal studies, such as reducing appetite and having anti-inflammatory effects.

Side effects

As with any drug, SB-204741 can have side effects. These can vary depending on the dose and individual response to the drug. Some potential side effects include nausea, vomiting, and dizziness.

See also

• 5-HT2B receptor
• Serotonin
• Serotonin antagonist

SB-204741 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia